[Effect of kontrikal on the dynamics of proteolytic system indices in postischemic toxemia]. 1987

V A Protsenko, and V Z Kharchenko, and Iu N Kolesnikov, and I F Spitsyn, and V E Egorychev

It was shown in Wistar male rats that the development of tourniquet shock was followed by an increase of proteolytic activity in the blood by 3 times, activity of aspartate aminotransferase (AST) by 3 times, that of alanine aminotransferase (ALT) by 6 times, contents of urea and residual nitrogen by 2.5-3 times; level of alpha 1-protease inhibitor (alpha 1-PI) decreased by 4 times and that of alpha 2-macroglobulin (alpha 2MG) by 2.5 times. At administration of contrykal (10,000 U/kg) proteolytic activity increased only by 32.5%, content of alpha 1-PI decreased only by 10-20% and level of alpha 2-MG did not differ from that in healthy animals. Activity of AST and ALT remained high, and contents of urea and residual nitrogen were near-normal.

UI MeSH Term Description Entries
D007611 Aprotinin A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) BPTI, Basic Pancreatic Trypsin Inhibitor,Basic Pancreatic Trypsin Inhibitor,Bovine Kunitz Pancreatic Trypsin Inhibitor,Kallikrein-Trypsin Inactivator,Kunitz Pancreatic Trypsin Inhibitor,Trypsin Inhibitor, Basic, Pancreatic,Trypsin Inhibitor, Kunitz, Pancreatic,Antilysin,Bovine Pancreatic Trypsin Inhibitor,Contrical,Contrykal,Dilmintal,Iniprol,Kontrikal,Kontrykal,Pulmin,Traskolan,Trasylol,Zymofren,Inactivator, Kallikrein-Trypsin,Kallikrein Trypsin Inactivator
D008297 Male Males
D010447 Peptide Hydrolases Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES. Peptidase,Peptidases,Peptide Hydrolase,Protease,Proteases,Proteinase,Proteinases,Proteolytic Enzyme,Proteolytic Enzymes,Esteroproteases,Enzyme, Proteolytic,Hydrolase, Peptide
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014111 Tourniquets Devices for the compression of a blood vessel by application around an extremity to control the circulation and prevent the flow of blood to or from the distal area. (From Dorland, 28th ed) Tourniquet
D014115 Toxemia A condition produced by the presence of toxins or other harmful substances in the BLOOD. Toxemias

Related Publications

V A Protsenko, and V Z Kharchenko, and Iu N Kolesnikov, and I F Spitsyn, and V E Egorychev
January 1979, Voprosy revmatizma,
V A Protsenko, and V Z Kharchenko, and Iu N Kolesnikov, and I F Spitsyn, and V E Egorychev
August 1985, Gematologiia i transfuziologiia,
V A Protsenko, and V Z Kharchenko, and Iu N Kolesnikov, and I F Spitsyn, and V E Egorychev
February 1976, Problemy gematologii i perelivaniia krovi,
V A Protsenko, and V Z Kharchenko, and Iu N Kolesnikov, and I F Spitsyn, and V E Egorychev
September 1969, American journal of obstetrics and gynecology,
V A Protsenko, and V Z Kharchenko, and Iu N Kolesnikov, and I F Spitsyn, and V E Egorychev
January 1984, Farmakologiia i toksikologiia,
V A Protsenko, and V Z Kharchenko, and Iu N Kolesnikov, and I F Spitsyn, and V E Egorychev
January 1995, Klinichna khirurhiia,
V A Protsenko, and V Z Kharchenko, and Iu N Kolesnikov, and I F Spitsyn, and V E Egorychev
January 1992, Vestnik oftalmologii,
V A Protsenko, and V Z Kharchenko, and Iu N Kolesnikov, and I F Spitsyn, and V E Egorychev
November 1981, Biulleten' eksperimental'noi biologii i meditsiny,
V A Protsenko, and V Z Kharchenko, and Iu N Kolesnikov, and I F Spitsyn, and V E Egorychev
October 1998, Biulleten' eksperimental'noi biologii i meditsiny,
V A Protsenko, and V Z Kharchenko, and Iu N Kolesnikov, and I F Spitsyn, and V E Egorychev
September 1999, Biulleten' eksperimental'noi biologii i meditsiny,
Copied contents to your clipboard!